With such a deluge of information, updates, and trial results, the HCPLive editorial team has collected 5 of the most impactful Phase 2 and 3 trials that should be on every clinician’s radar. Catch up on the biggest...
Children with eosinophilic esophagitis treated with dupilumab before age 6 had about half the asthma incidence of matched untreated peers 3.5 years later.